InternationalUSRemember you can easily switch between MIP US and MIP International at any time


Managing Intellectual Property has launched the Women in IP Network - a platform dedicated to bringing together women intellectual property professionals. With Managing IP's unparalleled access to leading IP lawyers, in-house counsel, academics and policy makers, we have created this niche community to facilitate the sharing of best practices and relationship building through an online network and events across the globe.

Benefits to joining the Network:

  • Invitations to breakfast seminars and cocktail receptions in various locations across the world
  • Delegate place at one of our Women's Forums in London, New York, San Jose/Bay area.
  • Exclusive membership to our online community
  • Access to articles commissioned exclusively for the online platform
  • Leadership Series - bi-monthly interviews with senior women executives
  • Best Practice Series - bi-monthly articles illustrating innovative initiatives
    around women lawyers, including law firm case studies and surveys
    around law firm policy and associate satisfaction
  • Quarterly live online Q&A sessions with expert panelists (CLE/CPD points)



If you are already a member log in at http://womeninip.managingip.com/

profile

Managing IP

ManagingIP

ManagingIP profile

RT @mdloney: SCOTUS TC Heartland v Kraft Foods Group Brands oral argument transcript is up! https://t.co/v29vEKCILp

Mar 27 2017 07:50 ·  reply ·  retweet ·  favourite
ManagingIP profile

Likely to be an important question for some applicants, with UPC due to come into force in December this year https://t.co/ASuSYUpRqd

Mar 27 2017 04:40 ·  reply ·  retweet ·  favourite
ManagingIP profile

Don't forget to sign up for our next webinar, on IP in Asia, this Thursday at 3pm (London) https://t.co/gh3Ka8t9q1 @inoviaIP @Minesoftnews

Mar 27 2017 04:38 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


March 2017

Roundtable: The second medical use challenge – full transcript

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



Most read articles

Supplements